Cognitive dysfunction among cancer survivors, commonly referred to as" chemobrain," has
gained increased attention in the last decade. Cognitive dysfunction is now well recognized …

Many cancer patients experience impairments of neurocognitive function, including memory
loss, distractibility, difficulty in performing multiple tasks (multitasking), and a myriad of other …

Malignant tumors and their various treatments such as chemotherapy, radiotherapy and
hormonal therapy can deleteriously affect a large number of cancer patients and survivors …

This brief review explores the areas of cognitive impairment that have been observed in
cancer patients and survivors, the cognitive assessment tools used, and the management of …

Decline in neuropsychologic test performance following adjuvant chemotherapy for various
types of cancer has gained much research attention over the past decade. From available …

A subset of survivors has cognitive impairment after cancer treatment. This is generally
subtle, but may be sustained. In October 2006, the second international cognitive workshop …

Approximately 13 million adult cancer survivors live in the United States; about 2 million of
them were diagnosed over 20 years ago (National Cancer Institute, 2012). Current 5-year …

Although the neurotoxicity of many anticancer therapies is well documented, the impact of
cancer treatment on cognitive functioning has been studied less frequently. The present …

Abstract Purpose/Objectives: To develop a conceptual model of chemotherapy-related
changes in cognitive function. Data Sources: MEDLINE®, CINAHL®, HealthStsr, and …

Objectives: The aim of this review is to stress the importance of cognitive dysfunction in
cancer survivors, and to discuss the way of assessing and managing these troubles in …